These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 35070064)
1. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. Huang A; Yang Y; Shi JY; Li YK; Xu JX; Cheng Y; Gu J World J Gastrointest Surg; 2021 Dec; 13(12):1567-1583. PubMed ID: 35070064 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma. Han F; Xu Y; Li X; Song Z; Xie J; Yao J Sci Rep; 2024 Aug; 14(1):18682. PubMed ID: 39134655 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma. Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Lin JK; Yang SH Front Oncol; 2021; 11():620146. PubMed ID: 33738258 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China. Huang A; Yang Y; Sun Z; Hong H; Chen J; Gao Z; Gu J Front Oncol; 2024; 14():1335678. PubMed ID: 38380362 [TBL] [Abstract][Full Text] [Related]
5. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Luo C; Cen S; Ding G; Wu W Cancer Commun (Lond); 2019 Mar; 39(1):13. PubMed ID: 30922401 [TBL] [Abstract][Full Text] [Related]
6. [Clinical features of colorectal mucinous adenocarcinoma]. Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341 [TBL] [Abstract][Full Text] [Related]
7. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine. Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539 [TBL] [Abstract][Full Text] [Related]
8. Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups. Chiang JM; Yeh CY; Changchien CR; Chen JS; Tang R; Chen JR Int J Colorectal Dis; 2010 Aug; 25(8):941-7. PubMed ID: 20532535 [TBL] [Abstract][Full Text] [Related]
9. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects. Debunne H; Ceelen W Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463 [TBL] [Abstract][Full Text] [Related]
10. MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer. Renaud F; Vincent A; Mariette C; Crépin M; Stechly L; Truant S; Copin MC; Porchet N; Leteurtre E; Van Seuningen I; Buisine MP Int J Cancer; 2015 Jun; 136(12):2811-21. PubMed ID: 25403854 [TBL] [Abstract][Full Text] [Related]
11. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188 [TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319 [TBL] [Abstract][Full Text] [Related]
13. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma. Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140 [TBL] [Abstract][Full Text] [Related]
14. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790 [TBL] [Abstract][Full Text] [Related]
15. Resistance to Cell Death in Mucinous Colorectal Cancer-A Review. O'Connell E; Reynolds IS; McNamara DA; Burke JP; Prehn JHM Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808549 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly: comparison with medullary type poorly differentiated adenocarcinoma. Arai T; Kasahara I; Sawabe M; Kanazawa N; Kuroiwa K; Honma N; Aida J; Takubo K Pathol Int; 2007 Apr; 57(4):205-12. PubMed ID: 17316416 [TBL] [Abstract][Full Text] [Related]
17. Comparison between colorectal low- and high-grade mucinous adenocarcinoma with MUC1 and MUC5AC. Onodera M; Nishigami T; Torii I; Sato A; Tao LH; Kataoka TR; Yoshikawa R; Tsujimura T World J Gastrointest Oncol; 2009 Oct; 1(1):69-73. PubMed ID: 21160777 [TBL] [Abstract][Full Text] [Related]
18. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. Verhulst J; Ferdinande L; Demetter P; Ceelen W J Clin Pathol; 2012 May; 65(5):381-8. PubMed ID: 22259177 [TBL] [Abstract][Full Text] [Related]
19. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer. Park JS; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK Medicine (Baltimore); 2015 Apr; 94(15):e658. PubMed ID: 25881840 [TBL] [Abstract][Full Text] [Related]
20. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]